HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SB202494

has no known p38 MAPK inhibitory effects
Also Known As:
4-ethyl-2-(4-methoxyphenyl)-5-(4-pyridyl)-1H-imidazole; SB 202474; SB 202494; SB-202474; SB-202494; SB202474
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Liu, Changjiang: 1 article (01/2018)
2. Yang, Min: 1 article (01/2018)
3. Zeng, Li: 1 article (01/2018)
4. Zhang, Pei: 1 article (01/2018)
5. Hara, A: 1 article (03/2010)
6. Hayashi, K: 1 article (03/2010)
7. Hoshino, T: 1 article (03/2010)
8. Ishii, T: 1 article (03/2010)
9. Nishimura, B: 1 article (03/2010)
10. Oikawa, K: 1 article (03/2010)

Related Diseases

1. Stomach Neoplasms (Stomach Cancer)
2. Hypothyroidism
3. Ototoxicity

Related Drugs and Biologics

1. SB 203580
2. p38 Mitogen-Activated Protein Kinases
3. Small Interfering RNA (siRNA)
4. Triclosan (pHisoHex)
5. 4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole